80

ProstateCancer

• Routine testing for prostate cancer does not save lives, study finds - GlobalPost 7 January, 2012, 3:08 pm
  RedOrbitRoutine testing for prostate cancer does not save lives, study findsGlobalPostRoutine screening for prostate cancer does not lower the risk of dying from the disease, according to the results of a large screening trial. Tyrone Pierre, of New Orleans, LA, attends a two-day free New Orleans Communities Are Responding Everyday ...Routine Prostate Cancer Screening Doesn't Reduce Risk of DeathABC NewsRockford man survives prostate cancer, becomes advocateRockford Register StarYearly prostate cancer screening fails to reduce deathsmsnbc.comPhysOrg.com -RedOrbit -Los Angeles Timesall 133 news articles »
• Cancer Deaths - Enormous Drop Over Last 20 Years, USA - Medical News Today 7 January, 2012, 12:08 pm
  Mesothelioma.comCancer Deaths - Enormous Drop Over Last 20 Years, USAMedical News TodayOver the last twenty years, more than one million deaths from cancer have been avoided, researchers reported in CA: A Cancer Journal for Clinicians. Death rates for the most common cancers, including colon, breast, prostate and lung cancers have been ...US Cancer Rates PlummetMesothelioma.comMost cancer rates declined over past two decadesWashington Post (blog)Cancer Incidence Drops for Some Cancers, Rises for OthersMedscapeNewsChannel 9 WSYR -WBIR-TV -OzarksFirst.comall 218 news articles »
• Dendreon shares climb after sales info release - BusinessWeek 7 January, 2012, 5:43 am
  BloombergDendreon shares climb after sales info releaseBusinessWeekTHE BIG PICTURE: Provenge is used as a treatment for prostate cancer that has not responded to previous therapies. The drug is designed to train a patient's immune system to fight the cancer. It was approved in April 2010, and it is the company's only ...Dendreon Reports GainsFor Costly Cancer DrugWall Street JournalDendreon Surges After Fourth-Quarter Product Revenue TriplesBloombergall 132 news articles »
• Rockford man survives prostate cancer, becomes advocate - Rockford Register Star 7 January, 2012, 7:37 am
  RedOrbitRockford man survives prostate cancer, becomes advocateRockford Register StarDavis battled prostate cancer last year and has become an advocate for prostate-specific antigen testing. $10 for $20 Worth of Italian Cuisine & Drinks at Joey C' Cucina & Cocktails! By Melissa Westphal Danny Davis had always been an advocate for his ...Regular Prostate Screenings Won't Reduce Cancer-Related Death RiskRedOrbitRoutine Prostate Cancer Screening Doesn't Reduce Risk of DeathABC NewsYearly prostate cancer screening fails to reduce deathsmsnbc.comNew York Times (blog) -Washington Post -Los Angeles Timesall 130 news articles »
• Lou Brock happy to help at Night of Memories - Evansville Courier & Press 7 January, 2012, 4:20 pm
  Lou Brock happy to help at Night of MemoriesEvansville Courier & PressBy Gordon Engelhardt DENNY SIMMONS / Courier & Press archives St. Louis Cardinals Hall of Fame outfielder Lou Brock greets those in attendance at Striking Out Prostate Cancer in Evansville in 2007. What: Night of Memories fund-raiser for youth sports. ...and more »
• Opting to Track, Not Treat, Early Prostate Cancer - Fox News 20 December, 2011, 6:58 am
  ThirdAgeOpting to Track, Not Treat, Early Prostate CancerFox NewsJohn Shoemaker visited six doctors in his quest to find the best treatment for his early stage prostate cancer — and only the last one offered what made the most sense to the California man: Keep a close watch on the tumor and treat only if it starts ...Prostate Cancer: Doctors Say Better Tests NeededThirdAgeMaking Sense of Cancer Screening UpdatesU.S. News & World ReportMy Turn: PSA scare prompts reflection and educationLos Angeles Timesall 216 news articles »
• FDA to Consider Additional Use for Amgen Bone Drug - Los Angeles Business Journal 30 December, 2011, 11:25 am
  Proactive Investors USA & CanadaFDA to Consider Additional Use for Amgen Bone DrugLos Angeles Business Journal8 to consider approving Xgeva for the treatment of men with some forms of prostate cancer who are at high risk of having their cancer spread to their bones. The FDA is scheduled to make a final decision by April 26. Approval could significantly boost ...FDA to Review Potential New Use of XGEVA® (Denosumab) at Oncologic Drugs ...MarketWatch (press release)FDA to look at secondary use for Amgen drug XgevaVentura County StarAmgen: Xgeva panel review scheduled for FebruaryBusinessWeekpharmabiz.com -Stock Markets Reviewall 35 news articles »
• FDA Panel to Review Amgen's Xgeva - Zacks.com 30 December, 2011, 7:31 am
  Proactive Investors USA & CanadaFDA Panel to Review Amgen's XgevaZacks.comAmgen is looking to get Xgeva approved for the treatment of men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases. The company had submitted a supplemental Biologics License Application (sBLA) for the drug in ...FDA to Review Potential New Use of XGEVA® (Denosumab) at Oncologic Drugs ...MarketWatch (press release)FDA to Consider Additional Use for Amgen Bone DrugLos Angeles Business JournalAmgen to meet with FDA panel in 2012 regarding new indication for XgevaProactive Investors USA & CanadaBoston.com -TopNews New Zealandall 35 news articles »
• Survey: TV doc urges patients to feed back experiences - Milton Keynes Today 1 January, 2012, 12:03 am
  Survey: TV doc urges patients to feed back experiencesMilton Keynes TodayTV doctor Hilary Jones has appealed to anyone affected by prostate cancer to take part in an important survey, launched by The Prostate Cancer Charity. Prostate cancer is the most common cancer in men with 37000 diagnosed with it each year in the UK. ...Very public healthBusiness Insiderall 4 news articles »
• Dendreon Starts Trial of Patients With Localized Prostate Cancer - Xconomy 7 January, 2012, 8:49 pm
  Dendreon Starts Trial of Patients With Localized Prostate CancerXconomyDendreon, the Seattle-based maker of immune-boosting therapies for cancer, said today it has started a mid-stage clinical trial of Provenge for patients with localized prostate cancer who are about to have their prostates surgically removed. ...and more »